|
Mar 11, 2010
|
ADVAXIS DEVELOPS ROOM TEMPERATURE FORMULATION OF ADXS11-001
|
|
Mar 10, 2010
|
EQUITY RESEARCH REPORT ON ADVAXIS UPDATED
|
|
Mar 8, 2010
|
ADVAXIS CONFIRMS LONG-TERM STABILITY OF LISTERIA-BASED IMMUNOTHERAPEUTICS' FORMULATIONS
|
|
Mar 4, 2010
|
ADVAXIS TO PRESENT AT THE FRENCH BIOTECH TOUR
|
|
Feb 19, 2010
|
ADVAXIS ANNOUNCES YEAR END 2009 RESULTS
|
|
Feb 19, 2010
|
ADVAXIS SUBMITS 10-K FOR FISCAL YEAR 2009
|
|
Feb 19, 2010
|
ADVAXIS CHAIRMAN/CEO THOMAS A. MOORE ISSUES STATEMENT
|
|
Feb 1, 2010
|
ADVAXIS CHAIRMAN/CEO THOMAS A. MOORE INTERVIEWED
|
|
Jan 27, 2010
|
ADVAXIS RECEIVES $278,978 IN NON-DILUTIVE TAX CREDIT SALE
|
|
Jan 22, 2010
|
ADVAXIS ISSUED NEW INTELLECTUAL PROPERTY PATENT
|
|
Jan 8, 2010
|
ADVAXIS TO PRESENT AT THE SIDOTI MICROCAP 2010 INVESTOR CONFERENCE
|
